ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselPAREXEL International (CH) AG
PAREXEL International (CH) AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

PAREXEL International (CH) AG is a clinical research organization (CRO) that provides services for pharmaceutical and biopharmaceutical clinical development. Services include Phase I–IV clinical trial management, regulatory strategy and submissions, drug safety and pharmacovigilance, real‑world evidence and market access support, as well as clinical trial supply and medical communications.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

PAREXEL International (CH) AG

✓ Offered9
Clinical Development Services
Clinical development for Phase I-IV studies, study design, patient recruitment and inclusion, clinical logistics, pharmacovigilance, and regulatory and medical communications.
Regulatory Approval and Market Access
Regulatory strategy, global submissions, compliance, market access, health economics modelling, and evidence generation for product approval and reimbursement.
Early Development and Innovation Consulting
Early-phase studies, biomarker and genomic medicine strategy, modelling, regulatory strategy, real-world evidence, clinical logistics, and integrated evidence planning.
Portfolio Management and Asset Valuation
Portfolio optimization, asset valuation, indication prioritization, early evidence review, and integrated development strategy and planning.
Value Substantiation and Lifecycle Management
Post-approval studies, real-world evidence, market access strategy, regulatory compliance, lifecycle optimization, and medical communications.
FSP and Functional Service Provider Models
FSP, hybrid, and FSO-style delivery models to scale trial resources, accelerate timelines, and improve efficiency.
Study Start-Up and Operational Excellence
Study start-up, process improvement, end-to-end execution, optimized operations, standardized methods, and faster study activation.
Therapeutic-Area Clinical Development
Clinical trials and therapeutic-area expertise in neuroscience, oncology, hematology, infectious disease and vaccines, immunology, ophthalmology, general medicine, and rare diseases.
AI-Enabled Clinical Development Platform (ParexelAI)
AI-enabled clinical development platform for faster, more efficient, and quality-focused clinical development operations.
Trust & reputation

ranQ Trust Score of PAREXEL International (CH) AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

PAREXEL International (CH) AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
PAREXEL International (CH) AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
PAREXEL International (CH) AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
PAREXEL International (CH) AG scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

PAREXEL International (CH) AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once PAREXEL International (CH) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

PAREXEL International (CH) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank PAREXEL International (CH) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of PAREXEL International (CH) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschenvorstadt 4
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-114.641.513
Founded
2008 · 18 years
Last commercial register change
June 16, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GV
    Global Value Web Swiss GmbH
    Basel
    IP
    Ironwood Pharmaceuticals GmbH
    Basel
    IG
    inhive Group (Switzerland) AG
    Basel
    EP
    Eumedica Pharmaceuticals AG
    Basel
    SR
    SFL Regulatory Affairs & Scientific Communication GmbH
    Basel
    IS
    Immunovant Sciences GmbH
    Basel
    ST
    Synendos Therapeutics AG
    Basel
    PS
    PreClinical Safety (PCS) Consultants Ltd
    Basel